The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: Phase I Acquired Immunodeficiency Syndrome Clinical Trials Group study (protocol 082)

Zidovudine Collaborative Working Group

Research output: Contribution to journalArticlepeer-review

139 Scopus citations

Fingerprint

Dive into the research topics of 'The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: Phase I Acquired Immunodeficiency Syndrome Clinical Trials Group study (protocol 082)'. Together they form a unique fingerprint.

Medicine & Life Sciences